Kumamoto-shi, Kumamoto
Kumamoto-shi, Kumamoto
Kumamoto-shi, Kumamoto, Japan8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis | Transthyretin Amyloid Cardiomyopathy (ATTR CM) | Active, not recruiting | Phase 2 | 2026-10-09 | NCT06260709 | |
| A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 3 | 2026-10-06 | NCT07861100 | |
| Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 3 | 2026-09-04 | NCT04822181 | |
| General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Not stated | 2026-08-27 | NCT06807190 | |
| Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin. | Blood Loss, Surgical, Hemic and Lymphatic Diseases, Hemorrhage, Intraoperative Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-08-21 | NCT07288489 | |
| Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed | Growth Hormone Deficiency in Children | Enrolling by invitation | Not stated | 2026-04-29 | NCT06109935 | |
| Special Use - Results Surveillance on Long-term Use With Wegovy® | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not stated | 2026-04-22 | NCT06283667 | |
| Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya® | Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hypopituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder | Active, not recruiting | Not stated | 2026-04-13 | NCT05230550 |